AnalystBook Research · Company Intelligence

CIMPRESS plc

CMPRNasdaq

Built from CIMPRESS plc's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Cimpress grew revenue, but cash flow and margins weakened.

The read at a glance✓ Audited against SEC data
  • Business mixPrint mass customizationNote
  • Revenue$3.40B, +3.4%OK
  • Net income$15.0M, -91.4%Watch
  • FCF$209.0M, -29.3%Watch
  • EquityDeficit worsenedWatch
  • Altman/Beneish/EQGrey Z; clean M/EQNote
  • Insiders1 purchase / 2 salesNote

Business

Cimpress is a collection of print mass-customization businesses selling small customized orders of printed materials, marketing products, signage, packaging, apparel, and related services.

Where the revenue comes from

Fiscal 2026, as CIMPRESS plc reports it. History and quarterly detail are in the app.

  • Vista$1.9B
  • PrintBrothers$823.2M
  • National Pen$446.8M
  • The Print Group$445.6M
  • All Other Businesses$258.1M

Leadership changes

From CIMPRESS plc's own filings, the day they're filed.

  • Wayne Ting · Directors · appointmenteff. 2025-05-27

Latest filings

  • 10-K · Annual report2026-08-07
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-07-02
  • 8-K · Company announcement2026-06-04
  • 8-K · Company announcement2026-05-11
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about CIMPRESS plc, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.